Mu-opioid receptors are involved in the tolerance to nicotine antinociception

Journal of Neurochemistry

Volumn 97, Issue 2, 2006, Pages 416-423

  Galeote, Lola ^a   Kieffer, Brigitte L ^b   Maldonado, Rafael ^a   Berrendero, Fernando ^a  

^a UNIVERSITAT POMPEU FABRA   (Spain)

^b INSTITUT DE GÉNÉTIQUE ET DE BIOLOGIE MOLÉCULAIRE ET CELLULAIRE   (France)

Author keywords

Knockout; Mice; Mu opioid receptor; Nicotine; Spinal cord; Tolerance

Indexed keywords

ENKEPHALIN[2 DEXTRO ALANINE 4 METHYLPHENYLALANINE 5 GLYCINE]; GUANOSINE 5' O (3 THIOTRIPHOSPHATE); MU OPIATE RECEPTOR; NICOTINE;

ANIMAL EXPERIMENT; ANTINOCICEPTION; ARTICLE; AUTORADIOGRAPHY; BINDING AFFINITY; CONTROLLED STUDY; MOUSE; NONHUMAN; NUCLEUS ACCUMBENS; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; PUTAMEN; SPINAL CORD; TAIL; WILD TYPE;

ANALGESICS, OPIOID; ANALYSIS OF VARIANCE; ANIMALS; AUTORADIOGRAPHY; BEHAVIOR, ANIMAL; BRAIN; DRUG ADMINISTRATION SCHEDULE; DRUG TOLERANCE; ENKEPHALIN, ALA(2)-MEPHE(4)-GLY(5)-; GUANOSINE 5'-O-(3-THIOTRIPHOSPHATE); MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; NICOTINE; NICOTINIC AGONISTS; PAIN MEASUREMENT; PROTEIN BINDING; RECEPTORS, OPIOID, MU; SPINAL CORD; SULFUR ISOTOPES; TIME FACTORS;

ANIMALIA;

EID: 33645293467     PISSN: 00223042     EISSN: 14714159     Source Type: Journal    
DOI: 10.1111/j.1471-4159.2006.03751.x     Document Type: Article

References (48)

1. Adams M. L. Cicero T. J. 1998 Nitric oxide mediates mecamylamine- and naloxone-precipitated nicotine withdrawal. Eur. J. Pharmacol. 345 R1 R2.
2. Bannon A. W. Decker M. W. Holladay M. W. et al. 1998 Broad-spectrum, non-opioid analgesic activity by selective modulation of neuronal nicotinic acetylcholine receptors. Science 279 77 81.
3. Berrendero F. Kieffer B. L. Maldonado R. 2002 Attenuation of nicotine-induced antinociception, rewarding effects, and dependence in mu-opioid receptor knock-out mice. J. Neurosci. 22 10 935 10 940.
4. Berrendero F. Mendizábal V. Robledo P. Galeote L. Bilkei-Gorzo A. Zimmer A. Maldonado R. 2005 Nicotine-induced antinociception, rewarding effects, and physical dependence are decreased in mice lacking the preproenkephalin gene. J. Neurosci. 25 1103 1112.
5. Carboni E. Bortone L. Giua C. Di Chiara G. 2000 Dissociation of physical abstinence signs from changes in extracellular dopamine in the nucleus accumbens and in the prefrontal cortex of nicotine dependent rats. Drug Alcohol Depend. 58 93 102.
6. Cordero-Erausquin M. Changeux J. P. 2001 Tonic nicotinic modulation of serotoninergic transmission in the spinal cord. Proc. Natl Acad. Sci. USA 98 2803 2807.
7. Cordero-Erausquin M. Pons S. Faure P. Changeux J. P. 2004 Nicotine differentially activates inhibitory and excitatory neurons in the dorsal spinal cord. Pain 109 308 318.
8. Cucchiaro G. Chaijale N. Commons K. G. 2005 The dorsal raphe nucleus as a site of action of the antinociceptive and behavioral effects of the alpha4 nicotinic receptor agonist epibatidine. J. Pharmacol. Exp. Ther. 313 389 394.
9. Damaj M. I. 2005 Calcium-acting drugs modulate expression and development of chronic tolerance to nicotine-induced antinociception in mice. J. Pharmacol. Exp. Ther. 315 959 964.
10. Damaj M. I. Martin B. R. 1996 Tolerance to the antinociceptive effect of epibatidine after acute and chronic administration in mice. Eur. J. Pharmacol. 300 51 57.
11. Decker M. W. Meyer M. D. 1999 Therapeutic potential of neuronal nicotinic acetylcholine receptor agonists as novel analgesics. Biochem. Pharmacol. 58 917 923.
12. Decker M. W. Rueter L. E. Bitner R. S. 2004 Nicotinic acetylcholine receptor agonists: a potential new class of analgesics. Curr. Top. Med. Chem. 4 369 384.
13. Flores C. M. 2000 The promise and pitfalls of a nicotinic cholinergic approach to pain management. Pain 88 1 6.
14. Ghelardini C. Galeotti N. Barlocco D. Bartolini A. 1997 Antinociceptive profile of the new nicotinic agonist DBO-83. Drug Dev Res. 40 251 258.
15. Gibaldi M. Perrier D. 1975 The trapezoid rule, in Pharmacokinetics Gibaldi M. Perier D., eds), pp. 293 296. Marcel Dekker New York.
16. Girdler S. S. Maixner W. Naftel H. A. Stewart P. W. Moretz R. L. Light K. C. 2005 Cigarette smoking, stress-induced analgesia and pain perception in men and women. Pain 114 372 385.
17. Grabus S. D. Martin B. R. Batman A. M. Tyndale R. F. Sellers E. Damaj M. I. 2005 Nicotine physical dependence and tolerance in the mouse following chronic oral administration. Psychopharmacology 178 183 192.
18. Houdi A. A. Dasgupta R. Kindy M. S. 1998 Effect of nicotine use and withdrawal on brain preproenkephalin A mRNA. Brain Res. 799 257 263.
19. Isola R. Zhang H. Duchemin A. M. Tejwani G. A. Neff N. H. Hadjiconstantinou M. 2002 Met-enkephalin and preproenkephalin mRNA changes in the striatum of the nicotine abstinence mouse. Neurosci. Lett. 325 67 71.
20. Iwamoto E. T. Marion L. 1993 Adrenergic, serotonergic and cholinergic components of nicotinic antinociception in rats. J. Pharmacol. Exp. Ther. 265 777 789.
21. Khan I. M. Wennerholm M. Singletary E. Polston K. Zhang L. Deerinck T. Yaksh T. L. Taylor P. 2004 Ablation of primary afferent terminals reduces nicotinic receptor expression and the nociceptive responses to nicotinic agonists in the spinal cord. J. Neurocytol. 33 543 556.
22. Kitchen I. Slowe S. J. Matthes H. W. Kieffer B. 1997 Quantitative autoradiographic mapping of mu-, delta- and kappa-opioid receptors in knockout mice lacking the mu-opioid receptor gene. Brain Res. 778 73 88.
23. Le Novère N. Corringer P. J. Changeux J. P. 2002 The diversity of subunit composition in nAChRs: evolutionary origins, physiologic and pharmacologic consequences. J. Neurobiol. 53 447 456.
24. Malin D. H. Lake J. R. Carter V. A. Cunningham J. S. Wilson O. B. 1993 Naloxone precipitates nicotine abstinence syndrome in the rat. Psychopharmacology 112 339 342.
25. Marubio L. M. del Mar Arroyo-Jimenez M. Cordero-Erausquin M. Lena C. Le Novere M. de Kerchove d'Exaerde A. Huchet M. Damaj M. I. Changeux J. P. 1999 Reduced antinociception in mice lacking neuronal nicotinic receptor subunits. Nature 398 805 810.
26. Matthes H. W. Maldonado R. Simonin F. et al. 1996 Loss of morphine-induced analgesia, reward effect and withdrawal symptoms in mice lacking the mu-opioid-receptor gene. Nature 383 819 823.
27. Molander C. Xu Q. Grant G. 1984 The cytoarchitectonic organization of the spinal cord in the rat. I. The lower thoracic and lumbosacral cord. J. Comp. Neurol. 230 133 141.
28. Paxinos G. Franklin K. B. J. 1997 The Mouse Brain in Stereotaxic Coordinates. Academic Press San Diego.
29. Pietila K. Lahde T. Attila M. Ahtee L. Nordberg A. 1998 Regulation of nicotinic receptors in the brain of mice withdrawn from chronic oral nicotine treatment. Naunyn Schmiedebergs Arch. Pharmacol. 357 176 182.
30. Pomerleau O. F. Turk D. C. Ferting J. B. 1984 The effects of cigarette smoking on pain and anxiety. Addict. Behav. 9 265 271.
31. Quick M. W. Lester R. A. 2002 Desensitization of neuronal nicotinic receptors. J. Neurobiol. 53 457 478.
32. Rogers D. T. Iwamoto E. T. 1993 Multiple spinal mediators in parenteral nicotine-induced antinociception. J. Pharmacol. Exp. Ther. 267 341 349.
33. Sim L. J. Selley D. E. Childers S. R. 1995 In vitro autoradiography of receptor-activated G proteins in rat brain by agonist-stimulated guanylyl 5′-[gamma-[35S]thio]-triphosphate binding. Proc. Natl Acad. Sci. USA 92 7242 7246.
34. Simonin F. Valverde O. Smadja C. et al. 1998 Disruption of the kappa-opioid receptor gene in mice enhances sensitivity to chemical visceral pain, impairs pharmacological actions of the selective kappa-agonist U-50,488H and attenuates morphine withdrawal. EMBO J. 17 886 897.
35. Sparks J. A. Pauly J. R. 1999 Effects of continuous oral nicotine administration on brain nicotinic receptors and responsiveness to nicotine in C57Bl/6 mice. Psychopharmacology 141 145 153.
36. Stevens C. W. Seybold V. S. 1995 Changes of opioid binding density in the rat spinal cord following unilateral dorsal rhizotomy. Brain Res. 687 53 62.
37. Suh H. W. Song D. K. Choi S. R. Chung K. M. Kim Y. H. 1996a Nicotine enhances morphine- and beta-endorphin-induced antinociception at the supraspinal level in the mouse. Neuropeptides 30 479 484.
38. Suh H. W. Song D. K. Lee K. J. Choi S. R. Kim Y. H. 1996b Intrathecally injected nicotine enhances the antinociception induced by morphine but not beta-endorphin, D-Pen2,5-enkephalin and U50,488H administered intrathecally in the mouse. Neuropeptides 30 373 378.
39. Tapper A. R. McKinney S. L. Nashmi R. et al. 2004 Nicotine activation of alpha4* receptors: sufficient for reward, tolerance, and sensitization. Science 306 1029 1032.
40. Trafton J. A. Abbadie C. Marek K. Basbaum A. I. 2000 Postsynaptic signaling via the [mu]-opioid receptor: responses of dorsal horn neurons to exogenous opioids and noxious stimulation. J. Neurosci. 20 8578 8584.
41. Tripathi H. L. Martin B. R. Aceto M. D. 1982 Nicotine-induced antinociception in rats and mice: correlation with nicotine brain levels. J. Pharmacol. Exp. Ther. 221 91 96.
42. Wang H. Sun X. 2005 Desensitized nicotinic receptors in brain. Brain Res. Brain Res. Rev. 48 420 437.
43. Wewers M. E. Dhatt R. K. Snively T. A. Tejwani G. A. 1999 The effect of chronic administration of nicotine on antinociception, opioid receptor binding and met-enkephalin levels in rats. Brain Res. 822 107 113.
44. Wonnacott S. 1990 The paradox of nicotinic acetylcholine receptor upregulation by nicotine. Trends Pharmacol. Sci. 11 216 219.
45. Wonnacott S. 1997 Presynaptic nicotinic Ach receptors. Trends Neurosci. 20 92 98.
46. Yoo J.-H. Lee S.-Y. Loh H. H. Ho I. K. Jang C.-G. 2004 Loss of nicotine-induced behavioral sensitization in μ-opioid receptor knockout mice. Synapse 51 219 223.
47. Zarrindast M. R. Pazouki M. Nassiri-Rad S. 1997 Involvement of cholinergic and opioid receptor mechanisms in nicotine-induced antinociception. Pharmacol. Toxicol. 81 209 213.
48. Zarrindast M. R. Khoshayand M. R. Shafaghi B. 1999 The development of cross-tolerance between morphine and nicotine in mice. Eur. Neuropsychopharmacol. 9 227 233.